-
1
Corrigendum: Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans
Published 2021-10-01Subjects: Get full text
Article -
2
HSP90 Inhibitor Ganetespib Enhances the Sensitivity of Mantle Cell Lymphoma to Bruton’s Tyrosine Kinase Inhibitor Ibrutinib
Published 2022-06-01Subjects: Get full text
Article -
3
Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans
Published 2021-05-01Subjects: Get full text
Article -
4
Ganetespib selectively sensitizes cancer cells for proximal and distal spread-out Bragg peak proton irradiation
Published 2022-04-01Subjects: Get full text
Article -
5
Synergistic Activity of the HSP90 Inhibitor Ganetespib With Lapatinib Reverses Acquired Lapatinib Resistance in HER2-Positive Breast Cancer Cells
Published 2021-07-01Subjects: “…ganetespib…”
Get full text
Article -
6
A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer
Published 2018-03-01Subjects: Get full text
Article -
7
A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer
Published 2017-08-01Subjects: “…Ganetespib…”
Get full text
Article -
8
Ganetespib with Methotrexate Acts Synergistically to Impede NF-κB/p65 Signaling in Human Lung Cancer A549 Cells
Published 2023-02-01Subjects: Get full text
Article -
9
-
10
Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer
Published 2019-01-01Subjects: Get full text
Article -
11
Hsp90 Inhibitor STA9090 induced VPS35 related extracellular vesicle release and metastasis in hepatocellular carcinoma
Published 2022-12-01Subjects: “…Ganetespib (STA9090)…”
Get full text
Article